Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $81.5900 (0.22%) ($79.5200 - $82.4850) on Thu. Nov. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.52% (three month average) | RSI | 49 | Latest Price | $81.5900(0.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.8% a day on average for past five trading days. | Weekly Trend | LGND declines -2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) IWM(50%) XBI(50%) IWC(49%) | Factors Impacting LGND price | LGND will decline at least -1.26% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-15%) UNG(-3%) EDOC(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.26% (StdDev 2.52%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $78.27(-4.07%) | Resistance Level | $84.08 | 5 Day Moving Average | $82.36(-0.93%) | 10 Day Moving Average | $83.03(-1.73%) | 20 Day Moving Average | $84.08(-2.96%) | To recent high | -29.1% | To recent low | 1.5% | Market Cap | $1.311b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |